SABCS 2014: SOFT Trial Commentary by Dr. Sunil Verma
: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone recep...
Author: oncologyeducation
Added: 12/11/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2014 Category: Cancer & Oncology Source Type: podcasts
Heart Health: Links to Pregnancy and Delivery
Factors that affect a woman's reproductive health can also have an effect on her heart, new research shows. Giving birth prematurely or delivering a small-for-gestational-age baby is associated with a later risk of cardiovascular disease in the mother. Another study found that when women's ovaries were removed and the estrogen was not replaced through hormone therapy, a woman's overall risk of dying increased, as did her risk of dying of heart disease or stroke. (Source: MUSC Heart and Vascular Podcast)
Source: MUSC Heart and Vascular Podcast - December 3, 2014 Category: Cardiology Authors: Medical University of South Carolina Source Type: podcasts
Continuing versus Intermittent Androgen Therapy
When primary therapy in the treatment of prostate cancer fails, hormonal therapy is normally the next step in managing the disease.
However much discussion has centered around whether intermittent ...
Author: vhsimons
Added: 12/01/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 1, 2014 Category: Cancer & Oncology Source Type: podcasts
Stress Hormone Receptors Less Adaptive in Female Brain
Transcript (Source: NIMH Audio)
Source: NIMH Audio - November 4, 2014 Category: Psychiatry Authors: National Institute of Mental Health Source Type: podcasts
Latest EASD Studies on Gastro-enteropancreatic Hormones
Gastro-enteropancreatic hormones and their clinical counterparts, medications based on GLP-1, are an active field of research. Michael Nauck, MD, summarizes the latest EASD studies on this topic. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - September 30, 2014 Category: Endocrinology Authors: Medscape Source Type: podcasts
Best Practices on Long-term Use of Menopausal HT
Dr. Andrew Kaunitz provides guidance on how to answer the common question, 'How long should I continue my hormone therapy?' (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - September 8, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts
Urogenital Atrophy: Vaginal Health for Menopausal Women
Women’s Health Podcast: Urogenital atrophy, also referred to as vaginal dryness is common, affecting as many as 15% of premenopausal women, 10-40% of postmenopausal women, and 10-25% of those taking systemic hormone therapy. Dr. Steven Swift, who specializes in Urogynecology, explains the signs and symptoms of urogenital atrophy and how to treat it with topical or oral estrogen treatments in this women’s health podcast. (Source: MUSC Urology Podcast)
Source: MUSC Urology Podcast - August 12, 2014 Category: Urology & Nephrology Authors: Medical Univeristy of South Carolina Source Type: podcasts
Nonhormonal Treatments for Hot Flashes Offer More Choices
Dr. JoAnn Manson discusses a new study comparing a hormonal and a nonhormonal treatment for reducing hot flashes. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 18, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts
Lessons From WHI, Part 3: Cost-Effectiveness
Drs. Black and Jackson discuss a new cost analysis that demonstrates the value of the WHI hormone therapy study. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - July 8, 2014 Category: Cardiology Authors: Medscape Source Type: podcasts
Lessons From the WHI, Part 1: Hormone Therapy
In part 1 of Dr. Black's interview with Dr. Rebecca Jackson, they review the landmark Women's Health Initiative findings on hormone therapy. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 8, 2014 Category: OBGYN Authors: Medscape Source Type: podcasts
Interview Dr. Hall C.F. Moore, ASCO 2014
Today at the ASCO Annual Meeting dr. Hall C.F. Moore, Cleveland Clinic, Ohio, presented the results of adding goserelin, a luteinizing hormone-releasing hormone analog, to cyclophosphamide-containing ...
Author: feeds
Added: 06/02/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2014 Category: Cancer & Oncology Source Type: podcasts
Breast Health: Breast Cancer Treatment Hard to Complete for Some
Fewer than half of women with early-stage breast cancer complete their full prescribed course of hormone therapy for breast cancer treatment, says a new study. The South Carolina breast cancer center of MUSC explores this topic in this podcast. (Source: MUSC Women's Health Podcast)
Source: MUSC Women's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts
Heart Health: Links to Pregnancy and Delivery
Factors that affect a woman's reproductive health can also have an effect on her heart, new research shows. Giving birth prematurely or delivering a small-for-gestational-age baby is associated with a later risk of cardiovascular disease in the mother. Another study found that when women's ovaries were removed and the estrogen was not replaced through hormone therapy, a woman's overall risk of dying increased, as did her risk of dying of heart disease or stroke. (Source: MUSC Women's Health Podcast)
Source: MUSC Women's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts
Women's Health: Bio-Identical Hormone Replacement Therapy
Both the Food and Drug Administration as well as physicians question the claims made regarding the safety and effectiveness of bio-identical hormone replacement therapy. (Source: MUSC Women's Health Podcast)
Source: MUSC Women's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts
Prostate Cancer: Treatment of Prostate Cancer, Part II
Choosing the best treatment for prostate cancer can be a difficult choice when there are 5 options available. Urologist, Dr. Thomas Keane, discusses three options in this cancer podcast; Radiation Therapy, Freezing and Hormones. Dr. Keane goes into detail for each treatment and weights the pros and cons for each one in this cancer podcast. (Source: MUSC Men's Health Podcast)
Source: MUSC Men's Health Podcast - April 5, 2014 Category: Primary Care Authors: Medical University of South Carolina Source Type: podcasts
